Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Asacard approved in U.K.

Feb. 4, 1998

New formulation of enalapril now available in U.K.

Feb. 4, 1998

Beneficial effects of vitamin C demonstrated in heart failure patients

Feb. 4, 1998

Hoechst reveals several series of Na+/H+ exchange inhibitors

Feb. 4, 1998

Second-generation DHEA derivative in development at Pharmadigm

Feb. 3, 1998

BASF presents new ET antagonists

Feb. 3, 1998

VasoCare approved in EU

Feb. 2, 1998

Mibefradil inhibits noradrenaline release via blockade of N-type Ca2+ channels

Feb. 2, 1998

BMS prepares MTP inhibitors for atherosclerosis and related diseases

Feb. 2, 1998

Caspase inhibitor reduces ischemia/reperfusion injury, attenuates apoptosis in vivo

Jan. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...